PUBLIC AND PATIENT INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT: A FRAMEWORK FORACTION

被引:94
|
作者
Abelson, Julia [1 ]
Wagner, Frank [2 ]
DeJean, Deirdre [3 ]
Boesveld, Sarah [3 ]
Gauvin, Francois-Pierre [4 ]
Bean, Sally [5 ]
Axler, Renata [6 ]
Petersen, Stephen [7 ]
Baidoobonso, Shamara [8 ]
Pron, Gaylene [7 ]
Giacomini, Mita [3 ]
Lavis, John [3 ]
机构
[1] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4L8, Canada
[2] Univ Toronto, Toronto, ON M5S 1A1, Canada
[3] McMaster Univ, Hamilton, ON L8S 4L8, Canada
[4] McMaster Hlth Forum, Hamilton, ON, Canada
[5] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[6] Univ Windsor, Odette Sch Business, Windsor, ON N9B 3P4, Canada
[7] Hlth Qual Ontario, Toronto, ON, Canada
[8] Canc Care Ontario, Toronto, ON, Canada
关键词
Public involvement; Patient involvement; Framework; Health technology assessment; PERSPECTIVES; ENGAGEMENT; CONSUMERS;
D O I
10.1017/S0266462316000362
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: As health technology assessment (HTA) organizations in Canada and around the world seek to involve the public and patients in their activities, frameworks to guide decisions about whom to involve, through which mechanisms, and at what stages of the HTA process have been lacking. The aim of this study was to describe the development and outputs of a comprehensive framework for involving the public and patients in a government agency's HTA process. Methods: The framework was informed by a synthesis of international practice and published literature, a dialogue with local, national and international stakeholders, and the deliberations of a government agency's public engagement subcommittee in Ontario, Canada. Results: The practice and literature synthesis failed to identify a single, optimal approach to involving the public and patients in HTA. Choice of methods should be considered in the context of each HTA stage, goals for incorporating societal and/or patient perspectives into the process, and relevant societal and/or patient values at stake. The resulting framework is structured around four actionable elements: (i) guiding principles and goals for public and patient involvement (PPI) in HTA, (ii) the establishment of a common language to support PPI efforts, (iii) a flexible array of PPI approaches, and (iv) on-going evaluation of PPI to inform adjustments over time. Conclusions: A public and patient involvement framework has been developed for implementation in a government agency's HTA process. Core elements of this framework may apply to other organizations responsible for HTA and health system quality improvement.
引用
收藏
页码:256 / 264
页数:9
相关论文
共 50 条
  • [31] Patient-centered health technology assessment: a perspective on engagement in health technology assessment by three patient organizations and a health technology assessment body
    Arntsen, Kathleen A.
    Blount, Linda G.
    Dickerson, Bradley J.
    Koola, Catherine P.
    Venable, Yvette
    Wildman, Patrick
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2022, 38 (01)
  • [32] Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries
    Dimitrova, Maria
    Jakab, Ivett
    Mitkova, Zornitsa
    Kamusheva, Maria
    Tachkov, Konstantin
    Nemeth, Bertalan
    Zemplenyi, Antal
    Dawoud, Dalia
    Delnoij, Diana M. J.
    Houyez, Francois
    Kalo, Zoltan
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [33] Public involvement in health research systems: a governance framework
    Fiona Alice Miller
    Sarah J. Patton
    Mark Dobrow
    Whitney Berta
    Health Research Policy and Systems, 16
  • [34] Patient and Public Involvement in Occupational Therapy Health Research: A Scoping Review
    Rossvoll, Toril Beate
    Hanssen, Tove Aminda
    Rosenvinge, Jan H.
    Liabo, Kristin
    Pettersen, Gunn
    OTJR-OCCUPATIONAL THERAPY JOURNAL OF RESEARCH, 2023, 43 (01): : 119 - 126
  • [35] Deliberative Processes by Health Technology Assessment Agencies: A Reflection on Legitimacy, Values and Patient and Public Involvement Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
    Goetghebeur, Mireille
    Cellier, Marjo
    INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2021, 10 (04) : 228 - 231
  • [36] PATIENT PERSPECTIVE IN HEALTH TECHNOLOGY ASSESSMENT OF PHARMACEUTICALS IN FINLAND
    Kleme, Jenni
    Pohjanoksa-Mantyla, Marika
    Airaksinen, Marja
    Enlund, Hannes
    Kastarinen, Helena
    Peura, Piia
    Hameen-Anttila, Katri
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2014, 30 (03) : 306 - 311
  • [37] What Is Next for Patient Preferences in Health Technology Assessment? A Systematic Review of the Challenges
    Huls, Samare P. I.
    Whichello, Chiara L.
    van Exel, Job
    Uyl-de Groot, Carin A.
    de Bekker-Grob, Esther W.
    VALUE IN HEALTH, 2019, 22 (11) : 1318 - 1328
  • [38] An uneven spread: A review of public involvement in the National Institute of Health Research's Health Technology Assessment program
    Moran, Rebecca
    Davidson, Peter
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2011, 27 (04) : 343 - 347
  • [39] Patients and public are important stakeholders in health technology assessment but the level of involvement is low – a call to action
    Janet L. Wale
    Samuel Thomas
    Dominique Hamerlijnck
    Ronald Hollander
    Research Involvement and Engagement, 7 (1)
  • [40] Health Technology Assessment and patient safety
    Mulcahy, Andrew
    Walley, Tom
    EPIDEMIOLOGY BIOSTATISTICS AND PUBLIC HEALTH, 2005, 2 (3-4) : 34 - 40